Nov 21, 04:05 PM

Harrow's ImprimisRx Wins $34.9 Million Jury Verdict in ImprimisRx, LLC v. OSRX, Inc.

Harrow Health's subsidiary, ImprimisRx, has been awarded $34.9 million by a jury in the case of ImprimisRx, LLC v. OSRX, Inc. The unanimous verdict includes both punitive and actual damages. This legal victory is significant for Harrow, as it reinforces the company's position in the pharmaceutical sector. In a related development, OSRX, Inc. has responded to the jury's verdict regarding trademark infringement, indicating ongoing legal implications for both parties involved.

#Harrow Health #ImprimisRx #LLC #OSRX #Inc #Harrow

Written with ChatGPT (GPT-4o mini).

Sources

Latest News from Business Wire@NewsFromBW
1 year ago
OSRX, Inc. Responds to Jury Verdict in Trademark Infringement Case https://t.co/k4BrS74aZn https://t.co/OkBC4GgmxX
Open Outcrier@OpenOutcrier
1 year ago
$LIFW (+38.5% pre) LifeWallet Announces a $2 Million Pharmaceutical Litigation Settlement - SI https://t.co/jSuQQwxLn3
dough@semodough
1 year ago
$HROW Harrow announces favorable jury verdict in ImprimisRx, LLC v. OSRX, Inc.; Receives $34.9 mln award for punitive and actual damages (42.44 million https://t.co/wvbhb7Wsqw

Additional media

Image #1 for story harrow-s-imprimisrx-wins-34-9-million-jury-verdict-imprimisrx-llc-v-osrx-inc-8e06d23f